Gene polymorphism and folate metabolism: A maternal risk factor for Down syndrome

Indian Pediatrics

Volumn 40, Issue 2, 2003, Pages 115-123

  Sheth, Jayesh J ^a,b   Sheth, Frenny J ^a  

^a FRIGE   (India)

^b NONE   (India)

Author keywords

Down syndrome; Folate; Homocysteine; Meiotic nondisjunction

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; DNA METHYLTRANSFERASE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHIONINE SYNTHASE;

CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; DOWN SYNDROME; ENZYME ACTIVITY; FEMALE; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; REVIEW; RISK FACTOR; TRISOMY 21; VITAMIN DEFICIENCY; VITAMIN METABOLISM;

DOWN SYNDROME; FERREDOXIN-NADP REDUCTASE; FLAVOPROTEINS; FOLIC ACID; HUMANS; MATERNAL AGE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0037327691     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Lejeune J, Gauthier M, Turpin R. Les chromosomes humans enculture de tissues. C R Acad Sci 1958; 248; 602-603.
2. Boue J, Bone A, Lazar P. Retrospective and prospective epidemiological studies of 1506 karyotyped spontaneous abortions. Teratology 1975; 12: 11-26.
3. Krivchenia E, Hether CA, Edmond LD, May DS. Comparative epidemiology of Down syndrome in two United States populations. Am J Epidemiol. 1993; 137: 815-825.
4. Hook CG. Epidemiology of Down syndrome. In: Pueschel, SM Rynders, JE. Down syndrome. Advances in Biomedicine and the Behavioral Sciences. Cambridge, Ware Press, 1982: pp 11-18.
5. Penrose LS. The relative effects of paternal and rhatemal age in mongolism. J Genet 1933; 27: 219-224.
6. Adams MM, Erickson JD, Layde PM, Oakley GP. Down's syndrome. Recent trends in the United States. JAMA 1981; 246: 758-760.
7. Petersen MB, Adlsberger PA, Schinzel AA, Binkert F, Hindkel GK, Antonarakis SE. Down syndrome due to de novo Robertsonian translocation t(14; 21): DNA polymorphism analysis suggests that the origin of the extra 21q is maternal. Am J Hum Genet 1991; 49: 529-536.
8. Antonarakis SE, Adel Berger PA, Peterson MB, Binkert F, Schinzel AA. Analysis of DNA polymorphism suggests that most de novo dup (21q) chromosomes in patients with DS are isochromosome and not translocations. Am J Hum Genet 1990; 47: 968-972.
9. Mikkelsen M. Down Syndrome. Cytogenetical epidemiology. Hereditas 1977; 6(1): 45-50.
10. Antonarakis ES and the Down Syndrome Collaborative Group. Prenatal origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphism. N Engl J Med 1991; 324: 871-876.
11. Yoon PW, Freeman SB, Sherman SL, Tarf LF, Gu Y, Pettay D, et al. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of the chromosome error. A population based study. Am J Hum Genet 1996; 58: 628-633.
12. Chandley AC. Maternal aging as the important factor in human aneuploidy. In: Dellaco VL, Voytek PE, Hollaender A (Eds): Aneuploidy. Etiology and Mechanisms. New York, Plenum, 1985; p 409-415.
13. Christman JK, Sheikhnejad G, Dizik M, Abileah S, Wainzan F. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 1993; 14: 551-557.
14. Frost P, Blom J, Milos R, Goyette P, Sheppard CA, Mathews TG, etal. A candidate genetic risk factor for vascular disease, a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
15. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristics of most cancers, is present in peripheral leucocytes of individuals who are homozygous for the C677T polymorphism in the MTHFR gene. Cancer Epidemiol Biomarkers Prev. 2000; 9: 849-853.
16. James SJ, Pogribna M, Pogribny IP, Melynk S, Jean Hine R, Gibson JB, et al. Abnormal folate metabolism and mutation in the MTHFR gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999; 70: 495-550.
17. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 2000; 67: 623-630.
18. Kutzback C, Stokstad EL. Mammalian MTHFR. Partial purification, properties and inhibition by 5-adenosylmethinone. Biochim Biophys Acta. 1971; 250: 459-477.
19. Goyette P, Summer J, Milos R, Duncan A, Rosenblatt D, Matthews R, et al. Isolation of cDNA for Human MTHFR and identification of mutations in MTHFR deficient patients. Am J Hum Genet 1993; 53(suppl): A 153.
20. Goyettee P, Summer JS, Milos R, Duncan AMV, Rosenblatt DS, Mathews RG, et al. Human MTHFR gene and genotype/phenotype correlations in severe MTHFR deficiency. Am J Human Genet 1994; 56: 1052-1059.
21. Goyette P, Aditya P, Renate M, Frosst P, Tran P, Chen Z, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mammalian Genome. 1998; 9:652-656.
22. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the MTHFR gene: an additional risk factor for neural tube defects. Am J Hum Genet 1998; 62: 1044-1055.
23. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, et al. Cloning and mapping of cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocysteinuria. Proc Natl Sci Acad USA. 1998; 95: 3059-3064.
24. Leclerc D, Odievre MH, Wu Q, Wilson A, Hizenga JJ, Rozen R, et al. Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. Gene 1999; 240: 75-78.
25. Pogribna M, Stepan M, Pogribny I, Chango A, Yi P. James SJ. Homocysteine metabolism in children with Down syndrome: In vitro modulation. Am J Hum Genet 2001; 69: 88-95.
26. Al-Gazali LI, Padmanabhan R, Melynk P, Yi P, Pogribny LP, Pogriban M, et al. Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with DS and neural tube defect. Am J Med Genet 2001; 103: 128-132.
27. Bailey LB, Gregory J. Polymorphisms of MTHFR and other enzymes; metabolic significance, risks and impact on folate requirement. J Nutr 1999; 129: 919-922.
28. Melynk S, Pogribna M, Pogribny IP, Yi P, James SJ. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteie utilizing colorimetric electrochemical detection; alterations with plasma homocysteine and pyriodoxal S-phosphate concentrations. Clin Chem 2000; 46: 265-272.
29. Chadefaux VB, Conde M, Muller F, Oury JF, Chabli A, Jais J, et al. Methylenetetrahydrofolate reductase polymorphism in the etiology of Down syndrome. Pediatr Res 2002, 51(6); 766-776.
30. O'Leary VB, Parlie-McDermott A, Molloy AM, Kirke PN, Johnson Z, Colney M, et al. MTRR and MTHFR polymorphism; Link to Down syndrome. Am J Med Genet 2002; 107: 151-155.
31. Stupia L, Gatta V, Gaspar AR, Antonucci I, Morizio E, Calabrese G, et al. C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy. Eur J Hum Genet 2002; 10: 388-390.
32. Mukherjee M, Joshi S, Bagadi S, Dalvi M, Rao A, Shetty KR. A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin Genet 2002; 61: 155-159.
33. Hasold T, Burrage L, Chan E, Judis L, Schwartz S, James SJ, et al. Maternal folate polymorphisms and the etiology of human nondysjunction. Am J Hum Genet 2001; 69: 434-439.